Figure 2From: Development and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasmaTypical chromatogram of glimepiride (12.5 μg mL-1), rosiglitazone (25 μg mL-1) and nicardipine HCl (20 μg mL-1) using acetonitrile/0.02 M phosphate buffer of pH 5 (60: 40, V/V) as a mobile phase.Back to article page